Sorry, you need to enable JavaScript to visit this website.

GREENSTONE LLC INTRODUCES PHENYTOIN TABLETS Generic of DILANTIN® INFATABS®

PEAPACK, N.J., December 2012 — Greenstone LLC, the U.S.-based generic pharmaceutical subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Phenytoin Tablets, USP to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strength of 50mg.

Greenstone’s Phenytoin Tablets, USP product is the authorized generic of, and equivalent to the innovator’s product, DILANTIN® (phenytoin, USP) INFATABS®. Their new authorized generic adds to Greenstone’s consistently growing line of products, and is backed by the power and scale of Pfizer’s 163-year worldwide reputation for a commitment to integrity, quality, and supply reliability. As a subsidiary of Pfizer, Greenstone operates under the same values and commitment to bring quality authorized generics to customers, payers, and the patients they serve.

See the Full Prescribing Information, for Greenstone’s Phenytoin Tablets, USP at http://www.greenstonellc.com/product-list.aspx. For more information about Greenstone LLC and its products, visit http://greenstonellc.com.